PISCATAWAY, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (“Enzon” or the “Company”) (Nasdaq:ENZN) announced today that its Board of Directors (the “Board”) has adopted a stockholder rights plan (the “Rights Plan”) in an effort to preserve the value of its net operating loss carryforwards (“NOLs”) under Section 382 of the Internal Revenue Code (the “Code”).
Help employers find you! Check out all the jobs and post your resume.
